Did Stryker Israel succeed in developing its flagship colonoscopy product to a commercial level? Was Sightline’s ColonoSight system already FDA-cleared for the U.S. market? What is the result of the pre-marketing clinical study to further validate the ColonoSight cost effectiveness? IIP > read on here > http://www.globes.co.il… All 71 employees of the medical device development [...]
Category Archives: Risk of intestinal perforation
Stryker closes Israel operations > Sightline Technologies > Innovative medical device > No commercializing and further development > ColonoSight system > Colonoscope with a disposable ColonoSleeve tube and sheath > Diagnosing and treating abnormalities > Large intestine > Intellectual property > EndoSight non-fiber optic colonoscope > Disposable ColonoSleeve multi-lumen tube > Covered by a compressed protective sheath > Electro-pneumatic System Control Unit SCU > Advanced IntraPull power-assisted disposable technology > Improves safety and speed > Protective sheath > Places disposable barrier > Gastroenterologists > Reducing risk of infection > Risk of intestinal perforation
Monday, December 22, 2008
Also filed in Advanced IntraPull power-assisted disposable technology, ColonoSight system, Colonoscope with a disposable ColonoSleeve tube and she, Covered by a compressed protective sheath, Diagnosing and treating abnormalities, Disposable ColonoSleeve multi-lumen tube, Electro-pneumatic System Control Unit SCU, EndoSight non-fiber optic colonoscope, Improves safety and speed, Innovative medical device, Intellectual property, Large intestine, No commercializing and further development, Places disposable barrier, Protective sheath, Reducing risk of infection, Sightline Technologies, Stryker closes Israel operations
|
|
Comments Off